Vitamin K nutrition and postmenopausal osteoporosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Estimating the causal effect of milk powder supplementation on bone mineral density: a randomized controlled trial with both non-compliance and loss to follow-up.European journal of clinical nutrition · 2015
   Trial
2. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2009
   Trial
3. The role of fat-soluble vitamins on bone metabolism and osteoporosis: a literature review.Annals of medicine · 2025
   Review
4. First Comparative Evaluation of Short-Chain Fatty Acids and Vitamin-K-Dependent Proteins Levels in Mother-Newborn Pairs at Birth.Life (Basel, Switzerland) · 2023
   Article
5. Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women.Journal of Korean medical science · 2010
   Article

Corrections and comments

• Comment on
  Dietary induced subclinical vitamin K deficiency in normal human subjects.1993
• Comment on
  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.1993

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as